Which plasma-derived product is used to correct coagulation defects in bleeding patients with multiple deficiencies?

Which plasma-derived product is used to correct coagulation defects in bleeding patients with multiple deficiencies?

• A. Platelets
• B. Albumin
• C. Fresh Frozen Plasma
• D. Cryoprecipitate

Answer: (C)

When bleeding stems from multiple coagulation factor deficiencies, you need a product that replenishes a broad range of clotting factors rather than just one or two components. Fresh frozen plasma provides all the coagulation factors (the broad spectrum of factors II, VII, IX, X and others, along with fibrinogen and regulatory proteins), making it the most suitable option to correct coagulopathy with multiple deficits. Cryoprecipitate, by contrast, mainly supplies fibrinogen and a few factors (like VIII and von Willebrand factor) and is not sufficient for widespread factor deficiencies. Platelets address platelet count or function, and albumin is used for volume or protein replacement, not coagulation. Therefore, Fresh Frozen Plasma best corrects the coagulation defects in this scenario.

When bleeding stems from multiple coagulation factor deficiencies, you need a product that replenishes a broad range of clotting factors rather than just one or two components. Fresh frozen plasma provides all the coagulation factors (the broad spectrum of factors II, VII, IX, X and others, along with fibrinogen and regulatory proteins), making it the most suitable option to correct coagulopathy with multiple deficits. Cryoprecipitate, by contrast, mainly supplies fibrinogen and a few factors (like VIII and von Willebrand factor) and is not sufficient for widespread factor deficiencies. Platelets address platelet count or function, and albumin is used for volume or protein replacement, not coagulation. Therefore, Fresh Frozen Plasma best corrects the coagulation defects in this scenario.